TP53 and cancer: Expression of the tumor suppressor gene TP53 was found to be significantly lower in PDAC tissues as compared to normal and benign tissues and expression levels significantly correlated with clinical outcomes, with lower TP53 associated with increased risk of cancer development and worse survival.